Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.

Eman M Khedr,Ahmed Abdelwarith, Gehad Moussa,Mostafa Saber

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association（2023）

引用 2|浏览1

暂无评分

摘要

Using rTPA is safe and effective in patients with AIS with or without COVID-19 infection despite the high frequency of hemorrhagic transformation and high number of deaths.

查看译文

关键词

Acute ischemic stroke,Covid-19,Outcomes,Recombinant tissue plasminogen activator

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要